{"id":"https://openalex.org/W2966135366","doi":"https://doi.org/10.1080/21645515.2019.1631136","title":"Tumor mutational burden as a predictive biomarker for checkpoint inhibitor immunotherapy","display_name":"Tumor mutational burden as a predictive biomarker for checkpoint inhibitor immunotherapy","publication_year":2019,"publication_date":"2019-07-30","ids":{"openalex":"https://openalex.org/W2966135366","doi":"https://doi.org/10.1080/21645515.2019.1631136","mag":"2966135366","pmid":"https://pubmed.ncbi.nlm.nih.gov/31361563","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7012182"},"language":"en","primary_location":{"id":"doi:10.1080/21645515.2019.1631136","doi":"https://doi.org/10.1080/21645515.2019.1631136","is_oa":true,"landing_page_url":"https://doi.org/10.1080/21645515.2019.1631136","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/21645515.2019.1631136?needAccess=true&role=button","source":{"id":"https://openalex.org/S2483136528","display_name":"Human Vaccines & Immunotherapeutics","issn_l":"2164-5515","issn":["2164-5515","2164-554X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Vaccines & Immunotherapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/21645515.2019.1631136?needAccess=true&role=button","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100620078","display_name":"Mark Andrew Lee","orcid":"https://orcid.org/0000-0002-5285-8266","observed_orcids":["https://orcid.org/0000-0002-5285-8266"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Lee","raw_affiliation_strings":["Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA","Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA","Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065142888","display_name":"Robert\u00a0M. Samstein","orcid":"https://orcid.org/0000-0001-6860-2401","observed_orcids":["https://orcid.org/0000-0001-6860-2401"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert M. Samstein","raw_affiliation_strings":["Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA","Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075803345","display_name":"Cristina Valero","orcid":"https://orcid.org/0000-0003-3397-2888","observed_orcids":["https://orcid.org/0000-0003-3397-2888"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cristina Valero","raw_affiliation_strings":["Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA","Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA","Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080223712","display_name":"Timothy An-thy Chan","orcid":"https://orcid.org/0000-0002-9265-0283","observed_orcids":["https://orcid.org/0000-0002-9265-0283"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Timothy A. Chan","raw_affiliation_strings":["Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA","Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA","Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084443648","display_name":"Luc G.T. Morris","orcid":"https://orcid.org/0000-0002-4417-2280","observed_orcids":["https://orcid.org/0000-0002-4417-2280"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Luc G.T. Morris","raw_affiliation_strings":["Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA","Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA","Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5080223712","https://openalex.org/A5084443648"],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":{"value":2895,"currency":"EUR","value_usd":3175},"apc_paid":null,"fwci":3.6511,"has_fulltext":true,"cited_by_count":76,"citation_normalized_percentile":{"value":0.94774273,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"16","issue":"1","first_page":"112","last_page":"115"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":1.0},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9599999785423279},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.996999979019165},{"id":"https://openalex.org/keywords/immunotherapy-response","display_name":"immunotherapy response","score":0.7879999876022339},{"id":"https://openalex.org/keywords/pan-cancer-analysis","display_name":"pan-cancer analysis","score":0.9390000104904175},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.45500001311302185}],"concepts":[{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6478915214538574},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6184044480323792},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.6180015206336975},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6082225441932678},{"id":"https://openalex.org/C3019719930","wikidata":"https://www.wikidata.org/wiki/Q3910099","display_name":"Predictive value","level":2,"score":0.5735020637512207},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5556200742721558},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47086918354034424},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4262758791446686},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1614244282245636},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023281","descriptor_name":"Genomics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1080/21645515.2019.1631136","doi":"https://doi.org/10.1080/21645515.2019.1631136","is_oa":true,"landing_page_url":"https://doi.org/10.1080/21645515.2019.1631136","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/21645515.2019.1631136?needAccess=true&role=button","source":{"id":"https://openalex.org/S2483136528","display_name":"Human Vaccines & Immunotherapeutics","issn_l":"2164-5515","issn":["2164-5515","2164-554X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Vaccines & Immunotherapeutics","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7012182","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7012182","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hum Vaccin Immunother","raw_type":"Text"},{"id":"pmid:31361563","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31361563","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human vaccines & immunotherapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:7fb4132624a1495d9394fc341844f60d","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/7fb4132624a1495d9394fc341844f60d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Human Vaccines & Immunotherapeutics, Vol 16, Iss 1, Pp 112-115 (2020)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1080/21645515.2019.1631136","doi":"https://doi.org/10.1080/21645515.2019.1631136","is_oa":true,"landing_page_url":"https://doi.org/10.1080/21645515.2019.1631136","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/21645515.2019.1631136?needAccess=true&role=button","source":{"id":"https://openalex.org/S2483136528","display_name":"Human Vaccines & Immunotherapeutics","issn_l":"2164-5515","issn":["2164-5515","2164-554X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Vaccines & Immunotherapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.75,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1676388581","display_name":null,"funder_award_id":"P30 CA008748","funder_id":"https://openalex.org/F4320314931","funder_display_name":"Pershing Square Sohn Cancer Research Alliance"},{"id":"https://openalex.org/G1959294861","display_name":"Identifying and targeting neoantigens in aggressive salivary carcinomas","funder_award_id":"R01DE027738","funder_id":"https://openalex.org/F4320337365","funder_display_name":"National Institute of Dental and Craniofacial Research"},{"id":"https://openalex.org/G2051006376","display_name":null,"funder_award_id":"CA008748","funder_id":"https://openalex.org/F4320309468","funder_display_name":"Memorial Sloan-Kettering Cancer Center"},{"id":"https://openalex.org/G2695170217","display_name":null,"funder_award_id":"P30 CA008748","funder_id":"https://openalex.org/F4320332898","funder_display_name":"Stand Up To Cancer"},{"id":"https://openalex.org/G3558678528","display_name":"Elucidating genetics of response to immune checkpoint blockade in lung cancer","funder_award_id":"R01CA205426","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4102770861","display_name":null,"funder_award_id":"CA008748","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4478570997","display_name":null,"funder_award_id":"R35 CA232097","funder_id":"https://openalex.org/F4320314931","funder_display_name":"Pershing Square Sohn Cancer Research Alliance"},{"id":"https://openalex.org/G5109122429","display_name":null,"funder_award_id":"P30 CA008748","funder_id":"https://openalex.org/F4320317082","funder_display_name":"Cycle for Survival"},{"id":"https://openalex.org/G5909372135","display_name":null,"funder_award_id":"P30 CA008748","funder_id":"https://openalex.org/F4320307770","funder_display_name":"AstraZeneca"},{"id":"https://openalex.org/G6114866700","display_name":"Dissecting the influence of DNA damage response and homologous recombination deficiencies on tumor immunogenicity","funder_award_id":"DP5OD028171","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G644517898","display_name":"Towards Precision Immuno-Oncology: Unraveling the Genomic Determinants and Mechanisms Underlying Immunotherapy Efficacy and Resistance","funder_award_id":"R35CA232097","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7877325548","display_name":null,"funder_award_id":"R01 CA205426","funder_id":"https://openalex.org/F4320314931","funder_display_name":"Pershing Square Sohn Cancer Research Alliance"},{"id":"https://openalex.org/G855853460","display_name":"Functionalizing recurrent FAT1 mutations and deletions in oral cancer","funder_award_id":"K08DE024774","funder_id":"https://openalex.org/F4320337365","funder_display_name":"National Institute of Dental and Craniofacial Research"},{"id":"https://openalex.org/G874817191","display_name":null,"funder_award_id":"CA205426","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000856728","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA008748","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320309468","display_name":"Memorial Sloan-Kettering Cancer Center","ror":"https://ror.org/02yrq0923"},{"id":"https://openalex.org/F4320314931","display_name":"Pershing Square Sohn Cancer Research Alliance","ror":"https://ror.org/02zhe7k92"},{"id":"https://openalex.org/F4320317082","display_name":"Cycle for Survival","ror":null},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332898","display_name":"Stand Up To Cancer","ror":"https://ror.org/01dmpb598"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337365","display_name":"National Institute of Dental and Craniofacial Research","ror":"https://ror.org/004a2wv92"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2966135366.pdf","grobid_xml":"https://content.openalex.org/works/W2966135366.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W2049553585","https://openalex.org/W2094366129","https://openalex.org/W2097995306","https://openalex.org/W2104885590","https://openalex.org/W2289712604","https://openalex.org/W2339890238","https://openalex.org/W2401455386","https://openalex.org/W2416791964","https://openalex.org/W2560367415","https://openalex.org/W2582671354","https://openalex.org/W2747774814","https://openalex.org/W2774712455","https://openalex.org/W2793364080","https://openalex.org/W2800160190","https://openalex.org/W2891795654","https://openalex.org/W2909679049","https://openalex.org/W2911721700","https://openalex.org/W2914335731","https://openalex.org/W2914458127","https://openalex.org/W2941582519","https://openalex.org/W2943781197","https://openalex.org/W4247679649"],"related_works":["https://openalex.org/W3084256642","https://openalex.org/W4386293163","https://openalex.org/W3164167181","https://openalex.org/W4221001936","https://openalex.org/W2909679049","https://openalex.org/W2987711192","https://openalex.org/W2913806219","https://openalex.org/W4389250357","https://openalex.org/W3097803258","https://openalex.org/W4362559507"],"abstract_inverted_index":{"Immune":[0],"checkpoint":[1],"inhibitor":[2],"(ICI)":[3],"therapies":[4],"can":[5],"achieve":[6,190],"meaningful":[7,51],"tumor":[8,52,85,138],"responses":[9],"in":[10,124],"a":[11,63,84,98,191],"subset":[12],"of":[13,18,27,74,83,101,127,136,158,194],"patients":[14,28,42],"with":[15,30,56,109,116,174],"most":[16],"types":[17],"cancer":[19,95,128],"that":[20,86,131,149,161],"have":[21],"been":[22],"investigated.":[23],"However,":[24],"the":[25,125,140],"majority":[26,126],"treated":[29,55],"these":[31],"drugs":[32],"do":[33],"not":[34,40],"experience":[35,49],"any":[36],"clinical":[37],"benefit.":[38],"Because":[39],"all":[41],"benefit":[43,195],"from":[44,196],"ICIs,":[45],"and":[46,112,181],"some":[47],"may":[48],"more":[50,71],"response":[53,114],"if":[54],"chemotherapy":[57],"or":[58],"other":[59,175],"treatments,":[60],"there":[61,150],"is":[62,80,151,162],"compelling":[64],"need":[65],"for":[66,90,164],"predictive":[67,88,142,170],"biomarkers":[68],"to":[69,153,188],"facilitate":[70],"informed":[72],"selection":[73],"therapy.":[75,118],"Tumor":[76],"mutational":[77],"burden":[78],"(TMB)":[79],"one":[81,155],"feature":[82],"has":[87],"value":[89],"ICI":[91,117,166],"therapy":[92],"across":[93],"multiple":[94],"types.":[96],"In":[97],"pan-cancer":[99],"analysis":[100],"over":[102],"1,600":[103],"patients,":[104],"higher":[105,113],"TMB":[106,132,160,173],"was":[107,122],"associated":[108],"longer":[110],"survival":[111],"rates":[115],"While":[119],"this":[120],"effect":[121],"seen":[123],"types,":[129],"indicating":[130],"underlies":[133],"fundamental":[134],"aspects":[135],"immune-mediated":[137],"rejection,":[139],"optimal":[141],"cut-point":[143],"varied":[144],"widely":[145],"by":[146],"histology,":[147],"suggesting":[148],"unlikely":[152],"be":[154,186],"tissue-agnostic":[156,192],"definition":[157],"high":[159],"useful":[163],"predicting":[165],"response.":[167],"More":[168],"comprehensive":[169],"models":[171],"integrating":[172],"factors":[176],"-":[177,184],"including":[178],"genetic,":[179],"immunologic,":[180],"clinicopathologic":[182],"markers":[183],"will":[185],"needed":[187],"potentially":[189],"predictor":[193],"ICIs.":[197]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":19},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":10}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-08-13T00:00:00"}